| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/03/2011 | US20110027258 Modified vitamin k-dependent polypeptides |
| 02/03/2011 | US20110027257 Clottable concentrate of platelet growth factors and preparation method thereof |
| 02/03/2011 | US20110027241 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
| 02/03/2011 | US20110027237 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells |
| 02/03/2011 | US20110027229 Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients |
| 02/03/2011 | US20110027220 Interleukin-1 Conjugates and Uses Thereof |
| 02/03/2011 | US20110027218 Tnf superfamily fusion proteins |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027176 Homing peptide for tumor vasculature |
| 02/03/2011 | CA2805505A1 Influenza viruses and uses thereof |
| 02/03/2011 | CA2771850A1 Method for purifying active gla-domain coagulation proteins |
| 02/03/2011 | CA2771835A1 Method for purifying gla-domain coagulation proteins |
| 02/03/2011 | CA2769673A1 Reverse genetics systems |
| 02/03/2011 | CA2769648A1 Use of collagen type vii for maintaining and re-inducing osteogenic abilities of mesenchymal stem cells |
| 02/03/2011 | CA2769643A1 Axmi-192 family of pesticidal genes and methods for their use |
| 02/03/2011 | CA2769340A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | CA2769229A1 Derivative of glp-1 analogue or its pharmaceutical salts and their use |
| 02/03/2011 | CA2769013A1 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| 02/03/2011 | CA2768997A1 High yield yellow fever virus strain with increased propagation in cells |
| 02/03/2011 | CA2768528A1 Method for detecting and identifying a variant c. difficile strain in a sample |
| 02/03/2011 | CA2768346A1 Antigenic tau peptides and uses thereof |
| 02/02/2011 | EP2280494A2 Method and apparatus for data transmission using multiple transmit antennas |
| 02/02/2011 | EP2280279A1 Method for evaluation of function of phagocyte |
| 02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| 02/02/2011 | EP2280073A2 Vaccine for prevention and treatment of HIV-infection |
| 02/02/2011 | EP2280072A2 Group B streptococcus antigens |
| 02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
| 02/02/2011 | EP2280063A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (RIP) saporin and saporin fusion chimaeras |
| 02/02/2011 | EP2280053A1 Circularly polarized light-emitting nanoparticle |
| 02/02/2011 | EP2280031A1 Cancer antigens based on products of the tumor suppressor gene WT1 |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2280029A1 Method for efficiently amplifying abnormal prion protein derived from bse |
| 02/02/2011 | EP2280028A1 Method for efficiently amplifying abnormal prion protein derived from sheep scrapie |
| 02/02/2011 | EP2280023A1 Tumor-associated peptides which bind to MHC molecules |
| 02/02/2011 | EP2280021A1 Pharmaceutical formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2280020A1 Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| 02/02/2011 | EP2280004A1 Pharmaceutique formulations comprising insulin complexed with a diketopiperazine |
| 02/02/2011 | EP2279758A2 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 02/02/2011 | EP2279756A2 Method for shielding functional sites or epitopes on proteins |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279746A2 Surface proteins in neisseria meningitidis |
| 02/02/2011 | EP2279412A2 Novel compositions and methods for the treatment of immune related diseases |
| 02/02/2011 | EP2279252A2 Use of rice polypeptides/nucleic acids for plant improvement |
| 02/02/2011 | EP2279210A2 Lysosomal targeting peptides and uses thereof |
| 02/02/2011 | EP2279205A1 Modified stefin a scaffold proteins |
| 02/02/2011 | EP2279204A1 Long-acting y2 and/or y4 receptor agonists |
| 02/02/2011 | EP2279203A2 Prion epitopes and methods of use thereof |
| 02/02/2011 | EP2279202A1 Multimeric forms of antimicrobial peptides |
| 02/02/2011 | EP2278994A2 Flagellin polypeptide vaccines |
| 02/02/2011 | EP2278992A2 Therapy for vitiligo |
| 02/02/2011 | EP2278991A1 Use of defensins against meningitis |
| 02/02/2011 | EP2027276B1 Antifungal polypeptides |
| 02/02/2011 | EP1618126B1 Sars-related proteins |
| 02/02/2011 | EP1447448B1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 02/02/2011 | EP1364212B1 Three hybrid assay system |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1301532B1 Plant cyclin-dependent kinase inhibitors |
| 02/02/2011 | EP1013763B1 Canine interleukin 18 production method |
| 02/02/2011 | CN201729784U Membrane separation device for concentrating thymosin solution |
| 02/02/2011 | CN101965409A Recombinant factor viii having increased stability |
| 02/02/2011 | CN101965405A Plants having enhanced yield-related traits and a method for making the same |
| 02/02/2011 | CN101965404A Novel bacillus thuringiensis gene with coleopteran activity |
| 02/02/2011 | CN101965397A Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |
| 02/02/2011 | CN101965361A Biological materials and uses thereof |
| 02/02/2011 | CN101965360A Novel bacillus thuringiensis gene with coleopteran activity |
| 02/02/2011 | CN101965359A Novel bacillus thuringiensis gene with coleopteran activity |
| 02/02/2011 | CN101965357A Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 02/02/2011 | CN101965199A Selenium containing modifying agents and conjugates |
| 02/02/2011 | CN101965131A Antifungal methods |
| 02/02/2011 | CN101962652A Complex of human glucagon-like peptide (GLP)-1 and preparation method thereof |
| 02/02/2011 | CN101962648A Duck source coronavirus ORF1a protein gene and cloning method and application thereof |
| 02/02/2011 | CN101962645A Method for promoting growth and lactation of mammary epithelial cells of milk cow |
| 02/02/2011 | CN101962644A Method for preparing swine novel gene BCL-GL polyclonal antibody |
| 02/02/2011 | CN101962643A Expression promoting sequences from mosses |
| 02/02/2011 | CN101962405A Humanized breast cancer antigen and antibody thereof |
| 02/02/2011 | CN101962404A Protein used for treating hemangioma |
| 02/02/2011 | CN101962403A Method for extracting silkworm pupa protein by utilizing microwave-assisted salt solution |
| 02/02/2011 | CN101962402A Astragalus membranaceus glycoprotein as well as preparation method and usage thereof |
| 02/02/2011 | CN101962368A Cyanurate hapten, artificial antigen and antibody, and preparation method and applications thereof |
| 02/02/2011 | CN101962359A Hapten, artifical antigen and antibody of enrofloxacin and preparation method as well as application thereof |
| 02/02/2011 | CN101962358A Ciprofloxacin hapten, artificial antigen and antibody and preparation method and application thereof |
| 02/02/2011 | CN101962343A Hapten, artificial antigen and antibody of basic orange as well as preparation method and application thereof |
| 02/02/2011 | CN101413004B Novel plant strong-salt resistance gene NHXFS1 and encoding protein |
| 02/02/2011 | CN101215329B Soluble human program death protein-1-lgV and preparation method thereof |
| 02/01/2011 | US7880057 Precise breeding—backbone integration markers |
| 02/01/2011 | US7880056 Signal transduction stress-related proteins and methods of use in plants |
| 02/01/2011 | US7880055 Lecitin-like protein kinase stress-related polypeptides and methods of use in plants |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| 02/01/2011 | US7879988 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
| 02/01/2011 | US7879982 19.5 polypeptide antibodies useful for diagnosing or treating psoriasis |
| 02/01/2011 | US7879980 Monoclonal antibodies to human CTLA-8 (IL-17A) |
| 02/01/2011 | US7879978 Macaca fascicularis ST2L |
| 02/01/2011 | US7879977 Methods and reagents for decreasing clinical reaction to allergy |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |